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ABSTRACT
Three experiments evaluated initial 
implant strategies for finishing cattle. In 
Exp. 1, heifers (n = 1,405; initial BW 
= 282 kg) were given (1) Revalor-IH 
followed by Revalor-200 (REV-IH/200), 
(2) Revalor-H followed by Revalor-200 
(REV-H/200), or (3) Revalor-200 fol-
lowed by Revalor-200 (REV-200/200). 
Intake, ADG, and G:F were not affected 
(P ≥ 0.14) by implant strategies, nor 
were HCW and LM area (P ≥ 0.16). 
Percent USDA Choice was greater (P 
< 0.01) for Rev-IH/200 compared with 
Rev-H/200 and Rev-200/200. Experi-
ment 2 used steers (n = 1,858; initial 
BW = 250 kg) given (1) Revalor-IS 
reimplanted with Revalor-200 (Rev-
IS/200), (2) Revalor-XS followed by 
Revalor-IS (Rev-XS/IS), (3) Revalor-XS 
followed by Revalor-S (Rev-XS/S), or 
(4) Revalor-XS followed by Revalor-200 
(Rev-XS/200). Implanting strategies 
did not affect (P ≥ 0.32) DMI or G:F. 
Carcass traits were not different (P ≥ 
0.18) among treatments, except steers 
implanted with Rev-XS/200 had greater 
(P < 0.01) LM area. In Exp. 3, steers 
(n = 1,408; initial BW = 305 kg) were 
given (1) Rev-IS/200, (2) Rev-200/200, 
or (3) Rev-XS/200. Gain and G:F 
did not differ (P ≥ 0.36) among the 
3 implant strategies, nor did HCW or 
marbling score (P ≥ 0.15). Steers given 
Rev-XS/200 had greater (P < 0.01) LM 
area and decreased (P ≤ 0.05) 12th-rib 
fat and YG compared with Rev-200/200 
and Rev-IS/200. Using Rev-200/200 and 
Rev-XS/200 increased (P = 0.03) USDA 
Select compared with Rev-IS/200. Using 
greater-initial-dose implant strategies 
may not affect ADG or G:F but appears 
to increase leanness.
Key words: carcass characteristic, 
finishing performance, implant strat-
egy
INTRODUCTION
Growth-promoting implants provide 
considerable improvements in pro-
duction efficiencies to the beef cattle 
industry (Folmer et al., 2009; Nichols 
et al., 2014). Despite these improve-
ments, the majority of implants only 
last 60 to 120 d, depending on the 
dose, before they are no longer ef-
fective. Because many cattle require 
more than 120 d to reach slaughter 
weight, reimplanting becomes an 
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important management strategy to 
improve animal efficiency (Preston, 
1999). For instance, cattle implanted 
with 2 consecutive combination im-
plants containing trenbolone acetate 
(TBA) and estradiol-17β (E2) have 
demonstrated a 20.0% increase in 
ADG and a 13.5% improvement in 
BW gain efficiency compared with 
nonimplanted cattle (Duckett and 
Pratt, 2014). Implanting strategies 
use different combinations of implants 
based on cattle, age, weight, sex, 
production goals, and estimated days 
on feed to target gain efficiency, lean 
meat yield, and carcass quality (Mad-
er, 1997; Reinhardt, 2007; Johnson et 
al., 2013). With demand for increased 
gain efficiency and lean meat yield, 
usage of greater-dose implants has 
increased; however, data are limited 
on the use of these implant combina-
tions in long-fed calves over 170 d. 
Therefore, the objectives of these 
experiments were to compare feedlot 
and carcass performance of long-fed 
heifers and steers receiving different 
aggressive initial implant strategies in 
commercial feedlots.
MATERIALS AND METHODS
The following experiments were 
conducted in collaborations between 
Merck Animal Health (De Soto, 
KS), Cattlemen’s Nutrition Service 
LLC (Lincoln, NE), Bos Terra LP. 
(Hobson, MT), Innovative Livestock 
Services Inc. (Great Bend, KS), and 
the University of Nebraska–Lincoln. 
Research was conducted at com-
mercial facilities and followed the 
guidelines stated in the Guide for the 
Care and Use of Agricultural Animals 
in Agricultural Research and Teaching 
(FASS, 2010).
Exp. 1
Animals and Treatments. Brit-
ish and British × Continental heifer 
calves (n = 1,405; 282 ± 3 kg of 
initial BW) were fed at a commercial 
feedyard in central Nebraska from 
May 2011 to November 2011 (days 
on feed across blocks averaged 173 
d). Heifers were sourced from sev-
eral sale barns located in Oklahoma. 
Treatments were (1) Revalor-IH (80 
mg of TBA + 8 mg of E2; Merck 
Animal Health, Madison, NJ) at 
initial processing followed 89 d later 
by Revalor-200 (200 mg of TBA + 
20 mg of E2; Merck Animal Health; 
REV-IH/200); (2) Revalor-H (140 
mg of TBA + 14 mg of E2; Merck 
Animal Health) at initial processing 
followed 89 d later by Revalor-200 
(REV-H/200); or (3) Revalor-200 at 
initial processing followed 89 d later 
by Revalor-200 (REV-200/200).
Heifers were allotted randomly to 
pen by arrival block (n = 6) by sort-
ing every 2 heifers into 1 of 3 pens 
before initial processing. Implant 
treatments were assigned randomly to 
pen (n = 1) within a block, for a total 
of 18 pens. After heifers were random-
ized into their respective pens, each 
pen was group weighed on a platform 
scale before processing to establish 
pen initial BW. Only products ap-
proved by the USDA and United 
States Food and Drug Administration 
were administered according to label 
directions during this study. At pro-
cessing, heifers received a combination 
vaccine (Bovi-Shield Gold, Zoetis Inc., 
Florham Park, NJ) against infectious 
bovine rhinotracheitis (IBR) virus, 
bovine virus diarrhea (BVD) virus 
types 1 and 2, parainfluenza 3 (PI3) 
virus, and bovine respiratory syn-
cytial virus (BRSV). Additionally, 
heifers received an oral dose of 10% 
fenbendazole solution (Safe-Guard, 
Merck Animal Health) for treatment 
of internal parasites, an injection of 
1% moxidectin (Cydectin, Boehringer 
Ingelheim/Vetmedica St. Joseph, MO) 
for treatment of external parasites, 
and an implant based on the speci-
fied treatment assigned. At reimplant 
(d 90), all pens within a block were 
brought to the processing facility, 
reimplanted with Revalor-200, and 
pen weighed.
Cattle were housed in 18 open lots 
with earthen mounds. Each animal 
had ad libitum access to clean water 
and their respective diet. Cattle were 
started on feed with a 56% concen-
trate, 44% roughage diet. Over a 26-d 
period, 2 intermediate diets were used 
to transition cattle to a finishing diet. 
The finishing diet consisted of 49.1% 
dry-rolled corn, 40% wet distillers 
grains plus solubles, 6.5% mixed hay, 
and 4.4% supplement (DM basis). 
The supplement was formulated to 
provide 300 mg per heifer daily of 
monensin (Rumensin; Elanco Animal 
Health, Indianapolis, IN), 90 mg per 
heifer daily of tylosin phosphate (Ty-
lan; Elanco Animal Health), and 0.45 
mg per heifer daily of melengestrol 
acetate (Heifermax; Elanco Animal 
Health). All heifers were fed zilpaterol 
hydrochloride at 8.33 mg/kg of DM 
(Zilmax; Merck Animal Health) for 20 
d followed by a 3-d withdrawal before 
slaughter. Heifers were fed twice daily 
at approximately 0700 and 1300 h in 
concrete, fence-line feedbunks, with 
feedbunks visually evaluated each 
morning. Feedbunks were managed to 
allow trace amounts of feed to remain 
in the bunk before feed delivery. Diet 
samples were obtained monthly from 
feedbunks and composited for nutri-
ent analysis (Servi-Tech Laboratories, 
Hastings, NE). Diets provided protein 
and minerals to meet or exceed NRC 
(1996) requirements and contained 
greater than 1.45 Mcal/kg of NEg.
Carcass Evaluation. Slaughter 
date was determined based on reim-
plant weight. Prior to shipping for 
slaughter, heifers from each pen were 
group weighed on platform scales and 
shrunk 4% to calculate DP and final 
live BW. After weighing, heifers were 
immediately loaded onto trucks and 
transported 201 km to a commercial 
abattoir (JBS, Grand Island, NE). 
Carcass-adjusted final BW was cal-
culated as average HCW divided by 
the average DP of 65.85% across all 
animals. Carcass data were collected 
by personnel from West Texas A&M 
University (Canyon, TX). Individual 
HCW were collected at slaughter, 
and following a 24-h chill, 12th-rib fat 
thickness, LM area, DP, KPH, mar-
bling scores, percent USDA QG, and 
percent USDA YG were collected for 
each pen. Yield grade was calculated 
using the equation of YG, where YG 
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= 2.50 + (6.35 × 12th-rib fat depth, 
cm) − (2.06 × LM area, cm2) + (0.2 
× KPH, %) + (0.0017 × HCW, kg) 
(Boggs and Merkel, 1993).
Exp. 2
Animals and Treatments. 
Crossbred steer calves (n = 1,858; 
initial BW 250 ± 19 kg) sourced from 
auction markets or ranches between 
October 11 and November 11, 2011, 
were fed at a commercial feedyard in 
central Montana (days on feed ranged 
from 196 to 238; average = 215). 
Treatments were (1) Revalor-IS (80 
mg of TBA and 16 mg of E2; Merck 
Animal Health) implant at initial 
processing followed by Revalor-200 
implant on d 120 (Rev-IS/200), (2) 
Revalor-XS (200 mg of TBA and 40 
mg of E2; Merck Animal Health) im-
plant at initial processing followed by 
Revalor-IS implant on d 140 (Rev-
XS/IS), (3) Revalor-XS implant at 
initial processing followed by Revalor-
S (120 mg of TBA and 24 mg of E2; 
Merck Animal Health) implant on d 
140 (Rev-XS/S), or (4) Revalor-XS 
implant at initial processing followed 
by Revalor-200 implant on d 140 
(Rev-XS/200).
Upon arrival steers were blocked 
by BW into heavy (>272 kg) or light 
(<272 kg) blocks. Once a replication 
was full (approximately 200 steers), 
cattle were assigned randomly at 
processing to treatment and pen (n 
= 32 total pens; 49 to 86 steers per 
pen). Altogether there were 8 pens 
per treatment, with 5 replications of 
treatment in the heavy block and 3 
replications of treatment in the light 
block. At processing, steers were 
individually weighed and received 
an individual electronic and visual 
feedlot identification tag; prophy-
lactic administration based on label 
recommendations of tulathromycin 
(Draxxin; Zoetis); a vaccine consist-
ing of IBR virus, BVD virus (types I 
and II), PI3 virus, BRSV, Mannheimia 
haemolytica and Pasteurella multocida 
(Vista Once; Merck Animal Health); 
a vaccine consisting of Clostridium 
chauvoei, Clostridium septicum, Clos-
tridium novyi, Clostridium sordellii, 
Clostridium perfringens types C&D 
(enterotoxemia), and Haemophilus 
somnus (Vision 7 Somnus; Merck 
Animal Health). Additionally, they 
received an oral dose of 10% fenben-
dazole solution (Safe-Guard; Merck 
Animal Health) for control of internal 
parasites; an injection of ivermectin 
(Ivomec; Merial, Duluth, GA) for con-
trol of internal and external parasites; 
and an implant based on the specified 
treatment assignment. At time of re-
implant, steers were given a terminal 
implant based on treatment protocol 
and also received a booster vaccine 
consisting of IBR, BVD (types I and 
II), PI3, and BRSV (Vista 5; Merck 
Animal Health) and an injection of 
ivermectin. All USDA and United 
States Food and Drug Administra-
tion approved products were used 
according to label directions. Within 
replication, steers in Rev-IS/200 
pens were reimplanted at 120 d on 
feed, and Rev-XS/IS, Rev-XS/S, and 
RevXS/200 pens were reimplanted at 
140 d on feed. Differences in reim-
plant date differed because the recom-
mended length of Rev-IS lasts up to 
120 d, whereas Rev-XS can last up to 
220 d.
Following initial processing, steers 
were group weighed by pen on a 
platform scale to establish pen ini-
tial BW to be used in performance 
calculations. Steers were housed in 
open feedlot pens and had ad libitum 
access to feed and water. Cattle were 
adapted to a common finishing diet 
over a 21-d period, and cattle were 
fed once daily at approximately 0700 
h. The finishing diet contained 61.24% 
wheat or barley, 20% corn dry distill-
ers grains plus solubles, 7.5% mixed 
wheat and barley silage, 7.5% alfalfa 
hay, and 3.76% supplement (DM 
basis). Diets were common across all 
pens over the feeding period, and any 
grain source changes were made to 
all treatments simultaneously. The 
supplement was formulated to provide 
monensin (Rumensin; Elanco Animal 
Health) at 300 mg per steer daily and 
tylosin phosphate (Tylan-40; Elanco 
Animal Health) at 90 mg per steer 
daily on a DM basis. Steers were 
fed zilpaterol hydrochloride (Zilmax; 
Merck Animal Health) at 8.33 mg/
kg of DM for 20 d followed by a 3-d 
withdrawal before slaughter. Diet 
samples were obtained monthly from 
feedbunks and composited for nutri-
ent analysis (Dairy One Labs, Ithaca, 
NY). Diets provided protein and min-
erals to meet or exceed NRC (1996) 
requirements and contained greater 
than 1.38 Mcal/kg of NEg.
Carcass Evaluation. Slaughter 
date was determined based on reim-
plant weight. Steers were weighed by 
pen on platform scales and shrunk 
4% before shipping to determine final 
shrunk BW. After weighing, steers 
were immediately loaded on trucks 
and transported approximately 1,036 
km to a commercial abattoir (JBS, 
Greeley, CO) for slaughter. Carcass-
adjusted final BW was calculated as 
HCW divided by a fixed DP of 61.0% 
across all steers. Carcass measure-
ments were reported by the abattoir 
based on USDA grades. Individual 
carcass measurements were collected 
using the procedures described in 
Exp. 1.
Exp. 3
Animals and Treatments. Ex-
periment 3 was conducted at a com-
mercial feedlot in central Nebraska 
from February 2, 2013, to October 15, 
2013 (days on feed ranged from 181 
to 209; average = 195 d). Cross-bred 
steers (n = 1,408; initial BW = 305 
± 10 kg) from ranches and auction 
barns in Nebraska, Nevada, and Utah 
were used for the trial. Treatments 
were (1) Revalor-IS given on d 1 fol-
lowed by Revalor-200 on d 115 (Rev-
IS/200); (2) Revalor-200 given on d 
1 followed by Revalor-200 on d 115 
(Rev-200/200); or (3) Revalor-XS 
given on d 1 followed by Revalor-200 
on d 115 (Rev-XS/200).
Steers were blocked (n = 3) by 
arrival date and projected slaughter 
date based on initial weight. Prior to 
processing, steers were allocated into 
1 of 3 sort pens by sorting every 2 
steers in the alley. Sort pens were as-
signed randomly to 1 of 3 treatments 
(n = 18; 68 to 95 steers per pen; 6 
pens per treatment).
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During initial processing, cattle 
were individually weighed; vaccinated 
against IBR, BVD (types I and II), 
PI3, and BRSV (Vista 3 SQ; Merck 
Animal Health); given an oral dose 
of 10% fenbendazole solution (Safe-
Guard, Merck Animal Health) for 
treatment of internal parasites and an 
injection of 1% moxidectin (Cydectin, 
Boehringer Ingelheim/Vetmedica) 
for treatment of external parasites; 
and individually identified. Following 
initial processing, steers were group 
weighed by pen on a platform scale to 
establish pen initial BW to be used 
in performance calculations. At time 
of reimplantation, all cattle within 
a replication were brought to the 
processing facility based on a random 
assignment of processing order and 
reimplanted with Revalor-200.
Steers were adapted to a common 
finishing diet over a 23-d transition 
period consisting of 3 adaptation di-
ets. The finishing diets were the same 
for each treatment but varied across 
time because of availability of ingre-
dients. Weighted averages were 49.9% 
dry-rolled corn (range 41.1–54.6%), 
19.2% ADM-Synergy (ADM, Colum-
bus, NE; range 0–28%), and 19.6% 
wet distillers grains with solubles 
(range 12–35%). The finishing diet 
also contained 5% liquid supplement 
(range 4.1–5.2%), 3.9% mixed hay 
(range 3.5–4.0%), and 2.4% corn 
silage (range 0–3%). The supplement 
was formulated to provide 360 mg per 
steer daily of monensin (Rumensin; 
Elanco Animal Health) and 90 mg per 
steer daily of tylosin phosphate (Ty-
lan; Elanco Animal Health). Because 
of timing of the trial, at the end of 
the feeding period, 3 replications were 
fed zilpaterol hydrochloride (Zilmax; 
Merck Animal Health) and 3 replica-
tions were fed ractopamine hydro-
chloride (Optaflexx; Elanco Animal 
Health). Zilpaterol was fed at a rate 
of 8.33 mg/kg of DM for 20 d followed 
by a 3-d withdrawal before slaughter. 
Ractopamine was fed at a rate of 300 
mg per steer daily for the last 28 d 
of the feeding period. Feeding of a 
β-agonist was equal across treatments 
and within a replication as all cattle 
were fed either Zilmax or Optaflexx 
and therefore not included in the 
statistical model. Diet samples were 
obtained monthly from the feedbunks 
and composited for nutrient analysis 
(Servi-Tech Laboratories). Diets pro-
vided protein and minerals to meet or 
exceed NRC (1996) requirements and 
contained greater than 1.45 Mcal/kg 
of NEg while on the finishing diet.
Carcass Evaluation. Steers were 
weighed by pen on platform scales 
and shrunk 4% before shipping to 
determine final shrunk BW. After 
weighing, cattle were immediately 
loaded on trucks and transported ap-
proximately 189 km to a commercial 
abattoir (JBS, Grand Island, NE) for 
slaughter. Carcass-adjusted final BW 
was calculated as HCW divided by 
the DP of 64.5% across all animals. 
Carcass data were collected by per-
sonnel from West Texas A&M Univer-
sity. Individual carcass measurements 
were the same as described in Exp. 1.
Deads-In and Deads-Out 
Calculations and Statistical 
Analysis
Deads-In Calculations. Calcula-
tions were made for initial weight 
by taking the initial pen average (no 
shrink) divided by the total num-
ber of cattle at the start of the trial 
(Exp. 1, 2, and 3). Final live BW was 
calculated using the total weight of 
pen at shipping (shrunk 4%) plus the 
weight of cattle sold early because of 
chronic sickness or injury, divided by 
the number of animals that started 
the trial (Exp. 1, 2, and 3). Deads-in 
ADG was calculated from the total 
kilograms gained (total final weight 
plus weight of cattle sold early minus 
total initial weight) divided by total 
number of animal days (Exp. 1, 2, 
and 3). Total DMI was calculated by 
dividing total feed delivered to the 
pen by the total number of animal 
days (Exp. 1, 2, and 3). Gain-to-feed 
ratio was calculated using the deads-
in ADG divided by DMI (Exp. 1, 2, 
and 3).
Deads-Out Calculations. Deads-
out initial weight was calculated the 
same as deads-in (Exp. 1 and 2). 
Deads-out initial BW was calculated 
by subtracting individual weight of 
dead steers or removals from the total 
initial pen weight, divided by the 
number of animals slaughtered (Exp. 
3). Final live BW was calculated us-
ing the total weight of cattle at ship-
ping (shrunk 4%) divided by the total 
number of cattle shipped excluding 
deads and cattle sold early (Exp. 1, 2, 
and 3). Deads-out ADG was deter-
mined by dividing the total weight 
gain (average final weight − aver-
age starting weight) by days on feed 
(Exp. 1, 2, and 3). Deads-out DMI 
was the same as deads-in, and G:F 
was calculated using deads-out ADG 
divided by DMI (Exp. 1, 2, and 3). 
Carcass-adjusted ADG and G:F were 
calculated using the same calculations 
as deads-out ADG and G:F (Exp. 1, 
2, and 3).
Statistical Analysis. Live perfor-
mance and carcass data were ana-
lyzed as a randomized complete block 
design using the Glimmix procedure 
of SAS (9.2, SAS Institute Inc., Cary, 
NC). Pen was the experimental unit 
and the model included the fixed ef-
fect of treatment, with block as a ran-
dom effect (Exp. 1 and 3). The model 
included replication as a random ef-
fect with experimental treatment and 
weight block as fixed effects (Exp. 2). 
Treatment averages were calculated 
using the LSMEANS option of SAS. 
Treatment differences were significant 
at an α value equal to or less than 
0.05. Frequency data were analyzed 
using the Glimmix procedure of SAS. 
The model specified a logistic link 
function for the binary response, with 
the number of animals slaughtered 
identified in the denominator. The 
means and SE of the proportions for 
the frequency data were determined 
using the ILINK option. Treatment 
differences were significant at an α 
value equal to or less than 0.05.
RESULTS AND DISCUSSION
Exp. 1—Performance
Deads-out live and carcass-adjusted 
BW, DMI, and ADG were not differ-
ent (P ≥ 0.14) between the 3 implant 
strategies (Table 1). Carcass-adjusted 
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Table 1. Effects of increased initial implant dose on growth performance and carcass characteristics of heifer 
calves fed for 173 d (Exp. 1)
Item
Treatment1
SE P-valueRev-IH/200 Rev-H/200 Rev-200/200
No. of heifers (pens) 473 (6) 466 (6) 466 (6) — —
Initial BW,2 kg 282 281 283 3.1 0.74
DMI,3 kg/d 9.70 9.57 9.69 0.05 0.14
Deads-in performance4      
 Live performance      
  Final BW, kg 529 542 532 12.3 0.35
  ADG, kg 1.50 1.56 1.51 0.06 0.44
  G:F 0.155 0.163 0.156 0.006 0.27
Deads-out performance5      
 Live performance      
  Final BW, kg 566 565 568 3.9 0.73
  ADG, kg 1.65 1.65 1.65 0.02 0.95
  G:F 0.170 0.172 0.171 0.001 0.28
 Carcass-adjusted performance6    
  Final BW, kg 568 564 568 3.9 0.16
  ADG, kg 1.65 1.64 1.66 0.15 0.33
  G:F 0.171 0.171 0.171 0.001 0.94
HCW, kg 374 371 374 2.6 0.16
DP, % 65.98 65.64 65.93 0.10 0.09
12th-rib fat thickness, cm 1.52 1.44 1.53 0.06 0.08
LM area, cm2 98.87 99.98 99.88 0.94 0.29
Marbling score7 428a 401b 400b 4.9 0.01
Calculated YG 2.61 2.46 2.58 0.09 0.06
USDA QG,8 %      
 Prime 0.69 0.45 0.92 0.46 0.72
 Choice 60.55a 49.10b 42.53b 2.38 <0.01
 Select 32.11a 43.89b 43.45b 2.38 <0.01
 ≤Standard 6.65a 6.56a 13.10b 1.62 0.01
USDA YG,8 %      
 1 11.81a 17.05b 18.14b 1.86 0.05
 2 38.43 36.36 42.33 2.34 0.22
 3 39.12a 37.27a 27.21b 2.35 <0.01
 4 10.19 8.18 10.93 1.51 0.39
 5 0.46 1.14 1.40 0.57 0.42
a,bMeans within a row with different superscripts differ (P < 0.05).
1Rev-IH/200 = Revalor-IH at processing and Revalor-200 at reimplant on d 89; Rev-H/200 = Revalor-H at processing and 
Revalor-200 at reimplant on d 89; Rev-200/200 = Revalor-200 at processing and Revalor-200 at reimplant on d 89. Revalor-IH, 
Revalor-H, Revalor-200, Merck Animal Health (De Soto, KS).
2Initial BW: total pen weight of cattle with no shrink divided by total number of starting heifers (deads-in and deads-out).
3DMI: calculated from total kilograms delivered to the pen divided by total number of animal days.
4Deads-in performance: ADG was calculated from total kilograms gained (total final weight plus removed weight after subtracting total 
starting weight) divided by total number of animal days. G:F was calculated from deads-in ADG divided by pen DMI.
5Deads-out performance: live ADG was calculated from total kilograms gained (average final weight subtracting average starting 
weight) divided by average days on feed. Live G:F was calculated from deads-out ADG divided by pen DMI. Carcass-adjusted 
performance ADG was calculated the same as live performance using carcass-adjusted final BW.
6Carcass-adjusted final BW was calculated as average HCW divided by the average DP of 65.85% across all animals.
7Marbling score: 400 = small00, 500 = modest00.
8The numbers represent by treatment the proportion of carcasses within each QG and YG category.
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G:F was not different (P = 0.94) and 
was 0.171 across all 3 implant treat-
ments. Similarly, there were no dif-
ferences (P ≥ 0.27) in deads-in ADG 
and G:F. Folmer et al. (2009) report-
ed that when comparing similar initial 
implant dosages, there were no dif-
ferences in DMI and live and carcass-
adjusted final BW. There were differ-
ences in live and carcass-adjusted G:F 
in heifers fed for 177 d (Folmer et al., 
2009). Guiroy et al. (2002) reported 
no differences in ADG and G:F for 
heifers implanted with either Rev-IH 
or Rev-H as an initial implant and 
Rev-H as a common terminal implant 
and fed for 189 d.
Carcass characteristics were not 
different (P ≥ 0.16) among the 3 
strategies for HCW and LM area. 
The Rev-H/200 implant combina-
tion did have a numerically lesser (P 
≥ 0.08) DP and 12th-rib fat thick-
ness, which could have contributed 
to a numerically lesser (P = 0.06) 
calculated YG compared with Rev-
IH/200 and Rev-200/200. Similar to 
this study, Schneider et al. (2007) 
reported no differences in 12th-rib 
fat thickness, HCW, LM area, and 
YG between carcasses of heifers that 
received similar implant protocols. 
Heifers that received Rev-IH/200 
had significantly greater (P = 0.01) 
marbling scores compared with the 
Rev-H/200 and Rev-200/200 treat-
ments. Quality grade distribution 
reflected this difference in marbling 
score with the Rev-IH/200 treat-
ment having a greater percentage 
(P < 0.01) of carcasses that graded 
Choice and a lesser percentage (P < 
0.01) of carcasses that graded Select 
compared with the Rev-H/200 and 
Rev-200/200 treatments. Addition-
ally, the Rev-IH/200 and Rev-H/200 
treatments had a lesser percentage (P 
= 0.01) of carcasses that graded less 
than or equal to Standard compared 
with the Rev-200/200 treatment. 
Schneider et al. (2007) and Folmer et 
al. (2009) reported no differences in 
marbling score; additionally, Folmer 
et al. (2009) reported no difference in 
the total number of carcasses grading 
Choice but a greater percentage of 
carcasses graded in the upper two-
thirds of Choice when a milder Rev-
IH/200 implant protocol was used.
The percentage of YG 1 carcasses 
was greater (P = 0.05) for Rev-
H/200 and Rev-200/200 than for 
Rev-IH/200. The percentage of YG 3 
carcasses was greater (P < 0.01) for 
Rev-IH/200 and Rev-H/200 com-
pared with Rev-200/200. In contrast 
to the current study, Folmer et al. 
(2009) reported no differences in the 
YG distribution. Consistent with our 
observations Hutcheson et al. (2002) 
reported no differences in gain during 
the finishing period but a decrease 
in marbling score as implant dosage 
was increased. Increasing the dosage 
of initial implant seems to have little 
effect on animal gains and feed effi-
ciency; however, the increased dosage 
could have negative effects on carcass 
fatness as evidenced by decreased 
yield and QG. Hutcheson et al. (2002) 
reported no differences in gain during 
the finishing period but a decrease in 
marbling score as implant dosage was 
increased.
Exp. 2—Performance
While previous studies have used 
Rev-XS as a single implant strategy 
for steers fed for 131 to 243 d on 
feed (Parr et al., 2011; Nichols et al., 
2014), there is little information avail-
able on using Rev-XS in combination 
with other implants to maximize 
production efficiency.
Cattle from different implanting 
strategies did not differ (P ≥ 0.11) 
in live or carcass-adjusted final BW; 
however, cattle that received Revalor-
XS as an initial implant numerically 
had heavier live and carcass-adjusted 
final BW (Table 2). Intake was not 
different (P = 0.38) across implant 
strategy. Although not statisti-
cally different (P ≥ 0.13), steers 
that received Rev-XS/IS, Rev-XS/S, 
and Rev-XS/200 had numerically 
greater deads-in and deads-out live or 
carcass-adjusted ADG compared with 
Rev-IS/200. Efficiency of gain was not 
different (P ≥ 0.32) among implant 
strategy on a live or carcass-adjusted 
basis. Parr et al. (2011) reported no 
differences in live and carcass-adjust-
ed final BW, DMI, ADG, and G:F for 
cattle implanted with Rev-IS followed 
by Rev-S at reimplant compared 
with a single implant of Rev-XS at d 
131, 174, and 243 on feed. Similarly, 
Nichols et al. (2014) reported no dif-
ferences in feedlot gain and efficiency 
after 157 d on feed when cattle were 
implanted with Rev-IS followed by 
Rev-S at reimplant compared with a 
single Rev-XS. Parr et al. (2011) re-
ported an increase in carcass-adjusted 
final BW and ADG when using a 
single Rev-XS implant for 197 d com-
pared with a Rev-IS/S implant pro-
gram and suggested that this could 
be due to decreased concentrations of 
TBA and E2 before reimplanting (d 
90 to 103), which caused a decrease 
in overall gain. Samber et al. (1996) 
evaluated different implant strategies 
using multiple implants with similar 
overall concentrations of TBA and 
E2 as those used in the current study, 
noting no differences in final BW, 
DMI, ADG, and G:F between the 
treatments.
In Exp. 2, HCW, DP, 12th-rib fat 
thickness, and marbling scores were 
not different (P ≥ 0.18) among im-
plant treatments. Nichols et al. (2014) 
reported no differences in HCW, 
12th-rib fat thickness, or marbling 
score when comparing Rev-XS with 
Rev-IS/S. Similarly, Parr et al. (2011) 
reported no differences in HCW, DP, 
and 12th-rib fat thickness between 
implant programs in cattle fed for 
174 or 243 d. Contrary to the current 
study, Samber et al. (1996) reported 
that cattle implanted 3 times with 
Rev-S compared with 2 times with 
Rev-S had less 12th-rib fat thickness.
Longissimus muscle area was largest 
(P < 0.01) for Rev-XS/200 implant 
programs, with Rev-XS/IS and Rev-
XS/S treatments being intermediate 
and Rev-IS/200 having the smallest 
LM area. Samber et al. (1996) also 
reported that increasing the amount 
of TBA and E2 used in the implant 
program increased LM area but had 
no effect on HCW or DP.
In Exp. 2, QG distributions were 
not different (P ≥ 0.19) by implant 
treatment. No significant differences 
(P ≥ 0.07) were observed between 
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Table 2. Effects of increased implant dose combinations on growth performance and carcass characteristics of 
steer calves fed for 216 d (Exp. 2)
Item
Treatment1
SE P-valueRev-IS/200 Rev-XS/IS Rev-XS/S Rev-XS/200
No. of steers (pens) 463 (8) 467 (8) 465 (8) 463 (8) — —
Initial BW,2 kg 255 257 257 256 2.9 0.60
DMI,3 kg/d 10.71 10.88 10.97 10.83 0.14 0.38
Deads-in performance4       
 Live performance       
  Final BW, kg 584 602 592 603 9.9 0.11
  ADG, kg/d 1.56 1.63 1.59 1.63 0.04 0.13
  G:F 0.146 0.150 0.145 0.151 0.004 0.32
Deads-out performance5      
 Live performance       
  Final BW, kg 615 624 621 624 8.0 0.11
  ADG, kg/d 1.60 1.70 1.68 1.70 0.03 0.13
  G:F 0.156 0.156 0.153 0.157 0.003 0.46
 Carcass-adjusted performance6      
  Final BW, kg 625 636 632 636 7.2 0.18
  ADG, kg/d 1.72 1.76 1.73 1.76 0.03 0.14
  G:F 0.160 0.161 0.158 0.163 0.002 0.36
HCW,7 kg 381 388 386 388 4.1 0.18
DP, % 62.28 62.63 62.52 62.63 0.6 0.40
12th-rib fat thickness, cm 1.23 1.23 1.23 1.18 0.04 0.47
LM area, cm2 88.75c 90.37b 90.16bc 91.96a 1.89 <0.01
Marbling score8 421 417 407 411 6.9 0.27
Calculated YG 2.90 2.88 2.87 2.75 0.09 0.06
USDA QG,9 %       
 Prime 0.96 1.38 1.18 1.62 0.61 0.86
 Premium Choice 14.94 11.24 10.85 10.65 1.75 0.20
 Low Choice 41.20 43.58 37.74 40.28 2.42 0.39
 Select 39.52 39.22 44.81 43.75 2.42 0.25
 ≤Standard 2.17 3.44 3.77 3.00 0.93 0.58
Dark cutter 1.21 1.15 1.65 0.69 0.62 0.66
USDA YG,9 %       
 1 10.36 10.78 13.68 12.96 1.67 0.38
 2 45.54 48.17 43.63 52.78 2.45 0.07
 3 37.35 35.55 36.56 30.32 2.38 0.16
 4 and 5 6.75 5.51 6.13 3.94 1.23 0.34
a–cMeans within a row with different superscripts differ (P < 0.05).
1Rev-IS/200 = Revalor-IS on d 0, Revalor-200 implant on d 120; Rev-XS/IS = Revalor-XS on d 0, Revalor-IS implant on d 140; Rev-
XS/S = Revalor-XS on d 0, Revalor-S implant on d 140; Rev-XS/200 = Revalor-XS on d 0, Revalor-200 implant on d 140. Revalor-IS, 
Revalor-S, Revalor-XS, Revalor-200, Merck Animal Health (De Soto, KS).
2Initial BW: total pen weight of cattle with no shrink divided by total number of starting steers (deads-in and deads-out).
3DMI: calculated from total kilograms delivered to the pen divided by total number of animal days.
4Deads-in performance: ADG was calculated from total kilograms gained (total final weight plus removed weight after subtracting total 
starting weight) divided by total number of animal days. G:F was calculated from deads-in ADG divided by pen DMI.
5Deads-out performance: live ADG was calculated from total kilograms gained (average final weight subtracting average starting 
weight) divided by average days on feed. Live G:F was calculated from deads-out ADG divided by pen DMI. Carcass-adjusted 
performance ADG were calculated the same as live performance using carcass-adjusted final BW.
6Carcass-adjusted final BW was calculated as HCW divided by the average DP of 61.0% across all steers.
7One replication was slaughtered early and no data were collected, so carcass characteristics were analyzed with only 7 replications.
8Marbling score: 400 = small00, 500 = modest00.
9The numbers represent by treatment the proportion of carcasses within each QG and YG category.
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Table 3. Effects of increased implant dose combinations on growth performance and carcass characteristics of 
steer calves fed for 195 d (Exp. 3)
Item
Treatment1
SE P-valueRev-IS/200 Rev-200/200 Rev-XS/200
No. of steers (pens) 473 (6) 471 (6) 464 (6) — —
Initial BW,2 kg 307 305 306 4.6 0.81
DMI,3 kg/d 11.05 11.12 10.98 0.16 0.58
Deads-in performance4      
 Live performance      
  Final BW, kg 633 633 632 7.0 0.99
  ADG, kg/d 1.72 1.72 1.71 0.06 0.95
  G:F 0.155 0.156 0.156 0.002 0.96
Deads-out performance5      
 Live performance      
  Final BW, kg 670 671 667 4.7 0.70
  ADG, kg/d 1.86 1.88 1.85 0.02 0.51
  G:F 0.168 0.170 0.169 0.002 0.49
 Carcass adjusted performance6     
  Final BW, kg 674 672 676 6.6 0.64
  ADG, kg/d 1.88 1.88 1.90 0.02 0.68
  G:F 0.170 0.170 0.173 0.003 0.36
HCW, kg 435 434 436 4.3 0.64
DP, % 64.88 64.67 65.31 0.4 0.11
LM area, cm2 96.73a 97.86a 100.75b 0.66 <0.01
12th-rib fat thickness, cm 1.78a 1.79a 1.67b 0.07 0.05
Marbling score7 475 457 461 13.3 0.15
Calculated YG 3.51a 3.44a 3.20b 0.10 0.01
USDA QG,8 %      
 Prime 2.50 1.13 1.37 0.74 0.28
 Premium Choice 27.73 23.13 25.06 2.13 0.32
 Low Choice 50.45 48.30 47.38 2.38 0.65
 ≤Select 19.32b 27.44a 26.20a 2.13 0.03
USDA YG,8 %      
 1 3.91a 5.91ab 8.95b 1.12 0.03
 2 22.07 25.45 29.59 2.19 0.07
 3 45.06 40.68 44.27 2.39 0.40
 4 25.75a 23.41a 15.83b 2.10 0.01
 5 3.22 4.55 1.38 0.99 0.06
a,bMeans within a row with different superscripts differ (P < 0.05).
1Rev-IS/200 = Revalor-IS at processing and Revalor-200 at reimplant on d 115; Rev-200/200 = Revalor-200 at processing and 
Revalor-200 at reimplant on d 115; Rev-XS/200 = Revalor-XS at processing and Revalor-200 at reimplant on d 115. Revalor-IS, 
Revalor-200, Revalor-XS, Merck Animal Health (De Soto, KS).
2Initial BW: total pen weight of cattle with no shrink subtracting individual weights of dead or removed animals divided by the number 
of remaining animals (deads-out).
3DMI: calculated from total kilograms delivered to the pen divided by total number of animal days.
4Deads-in performance: ADG was calculated from total kilograms gained (total final weight subtracting total starting weight with deads 
and removed included) divided by total number of animal days. G:F was calculated from deads-in ADG divided by pen DMI.
5Deads-out performance: live ADG was calculated from total kilograms gained (average final weight subtracting average starting 
weight) divided by average days on feed. Live G:F was calculated from deads-out ADG divided by pen DMI. Carcass-adjusted 
performance ADG were calculated the same as live performance using carcass-adjusted final BW.
6Carcass-adjusted final BW was calculated as HCW divided by the DP of 64.5% across all animals.
7Marbling score: 400 = small00, 500 = modest00.
8The numbers represent by treatment the proportion of carcasses within each QG and YG category.
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treatments for any of the YG cat-
egories; however, the Rev-IS/200 
and the Rev-XS/S numerically had a 
lesser percentage of YG 2 carcasses, 
which led to an increase in YG 3 
carcasses compared with Rev-XS/IS 
and Rev-XS/200. Parr et al. (2011) 
and Nichols et al. (2014) noted differ-
ences in the percentage of Choice and 
Select carcasses in cattle fed for 131, 
157, and 243 d, with cattle receiv-
ing a single Rev-XS implant having 
more Choice and less Select grading 
carcasses compared with RevIS/S. 
Parr et al. (2011), however, reported 
no differences in QG distribution in 
cattle fed for 174 and 197 d. Vary-
ing the timing of reimplant could 
have affected QG distribution in 
these studies. Similarly, Nichols et al. 
(2014) reported no differences in YG 
distribution.
Exp. 3—Performance
There were no differences (P ≥ 
0.36) in live or carcass-adjusted cattle 
performance among the 3 implant 
strategies (Table 3). As in Exp. 2, fi-
nal live and carcass-adjusted BW did 
not differ (P ≥ 0.64) among implant 
programs. Similarly, deads-out car-
cass-adjusted ADG and G:F were not 
different (P ≥ 0.36) between implant 
strategy, agreeing with observations 
from Exp. 2. These results are con-
sistent with Samber et al. (1996) and 
Nichols et al. (2014), who reported no 
differences in DMI, ADG, G:F, and 
final BW between implant strategies 
of increased TBA and E2 dose. Addi-
tionally, there were no differences (P 
≥ 0.15) in HCW or USDA marbling 
score when comparing the 3 treat-
ments (Table 3). The Rev-XS/200 
treatment group had greater (P < 
0.01) LM area, decreased (P ≤ 0.05) 
12th-rib fat thickness, and calculated 
YG compared with the Rev-200/200 
and Rev-IS/200 treatments. Similar 
to Exp. 2, the Rev-IS/200 and Rev-
XS/200 treatments were used; how-
ever, reimplant occurred on the same 
day on feed (d 115) in Exp. 3 but dif-
fered between Rev-IS/200 (d 120) and 
Rev-XS/200 (d 140) in Exp. 2. This 
delay in implanting between the Rev-
IS/200 and Rev-XS/200 treatments 
could explain why there were no dif-
ferences observed for carcass charac-
teristics in Exp. 2 but a difference in 
Exp. 1. Samber et al. (1996) reported 
no differences in HCW between ag-
gressive implant strategies but noted 
a decrease in 12th-rib fat thickness 
and calculated YG as implant dosage 
increased.
Table 4. Health data for calf-fed heifers and steers implanted with different aggressive implant strategies
Item1
Treatment2
SE P-valueRev-IH/200 Rev-H/200 Rev-200/200
Exp. 1
 Morbidity (total pulls),3 % 10.57b 16.31a 12.23ab 1.71 0.05
 Mortalities,4 % 3.59 1.29 2.58 0.86 0.12
 Removal,5 % 2.96 2.58 3.86 0.89 0.53
Rev-IS/200 Rev-XS/IS Rev-XS/S Rev-XS/200
Exp. 2
 Morbidity (total pulls),3 % 15.98ab 16.92ab 21.08a 12.53b 1.89 0.02
 Mortalities,4 % 5.62 3.64 4.30 3.02 1.07 0.26
 Removal,5 % 0.00 0.21 0.86 0.86 0.43 0.63
Rev-IS/200 Rev-200/200 Rev-XS/200
Exp. 3
 Morbidity (total pulls),3 % 15.64 13.38 14.01 1.67 0.60
 Mortalities,4 % 1.48  1.06 1.51 0.57 0.81
 Removal,5 % 4.23  4.67 3.66 0.97 0.75
1The numbers represent by treatment the proportion of animals within each category treated for morbidity, mortalities, or removed.
2Exp. 1: Rev-IH/200 = Revalor-IH at processing and Revalor-200 at reimplant on d 89; Rev-H/200 = Revalor-H at processing and 
Revalor-200 at reimplant on d 89; Rev-200/200 = Revalor-200 at processing and Revalor-200 at reimplant on d 89. Exp. 2: Rev-
IS/200 = Revalor-IS at initial processing followed by Revalor-200 implant on d 120; Rev-XS/IS = Revalor-XS at initial processing 
followed by Revalor-IS implant on d 140; Rev-XS/S = Revalor-XS implant at initial processing followed by Revalor-S implant on d 
140; Rev-XS/200 = Revalor-XS implant at initial processing followed by Revalor-200 implant on d 140. Exp. 3: Rev-IS/200 = Revalor-
IS at processing and Revalor-200 at reimplant on d 115; Rev-200/200 = Revalor-200 at processing and Revalor-200 at reimplant on 
d 115; Rev-XS/200 = Revalor-XS at processing and Revalor-200 at reimplant on d 115. Revalor-IH, Revalor-H, Revalor-200, Revalor-
IS, Revalor-S, Revalor-XS, Merck Animal Health (De Soto, KS).
3Morbidity = any animals treated for sickness during the trials.
4Mortality = any animals that died from d 0 to the end of the trial.
5Removal = any animals that were removed from the trial and sold early because of chronic sickness or injury.
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The percentage of YG 1 carcasses 
was greater (P = 0.03) for Rev-
XS/200 compared with Rev-IS/200 
carcasses. There was a decrease (P 
= 0.01) in the percentage of YG 4 
carcasses in Rev-XS/200 carcasses 
compared with Rev-200/200 and Rev-
IS/200 carcasses. This shift in YG 
distribution is the result of differences 
in LM area and 12th-rib fat thickness.
There were no differences (P ≥ 
0.28) in the percentage of cattle that 
graded Choice or greater; however, 
the Rev-200/200 and Rev-XS/200 
treatments had an increase (P = 0.03) 
in the percentage of carcasses that 
graded USDA Select compared with 
Rev-IS/200. Samber et al. (1996) 
reported that there was a decrease in 
the percentage of Choice and Prime 
grading carcasses as implant dosage 
was increased. Similarly, Nichols et al. 
(2014) reported no differences in QG 
distribution between steers implanted 
with Rev-IS/S or Rev-XS. Differences 
in carcass characteristics between 
Exp. 2 and 3 could be due to differ-
ences in reimplant date, cattle weight, 
BW, and cattle handling at reimplant 
in addition to environmental factors 
as similar differences between implant 
strategies were noted by Parr et al. 
(2011) and Nichols et al. (2014).
Animal Health
Morbidity differences (P < 0.05) 
were detected with Rev-IH/200 hav-
ing the least, Rev-200/200 being 
intermediate, and Rev-H/200 having 
the greatest (P = 0.05) percentage 
of morbidity (Table 4). However, 
there were no differences (P ≥ 0.12) 
in mortality or rejected-percentage. 
Rev-XS/200 had the lowest morbid-
ity percentage, and Rev-XS/S had 
the greatest (P = 0.02). However, as 
noted in Exp. 1, there were no differ-
ences (P ≥ 0.26) in the mortality or 
rejected-percentage. In Exp. 3 there 
were no differences (P ≥ 0.60) in the 
number of animals treated for illness, 
mortalities, or removed animals. Mun-
son et al. (2012) reported that there 
were numerical differences in steer 
morbidity and no differences in steer 
mortality when comparing an initial 
to a delayed implant treatment simi-
lar to a lesser- and greater-dose initial 
implant, which is in agreement with 
the current steer studies. Additionally, 
Gruber et al. (2011) reported no dif-
ferences in morbidity between implant 
treatments in both steers and heifers. 
Whereas differences in morbidity in 
Exp. 1 and 2 were detected and not in 
Exp. 3, these data would suggest that 
increased initial implant dosage does 
not have an effect on animal health.
IMPLICATIONS
Economic incentives have led to use 
of more aggressive implant strategies 
to illicit a greater gain and efficiency 
response. However, it appears the use 
of aggressive implant strategies and 
increased dosages may not be ben-
eficial for daily gain and efficiency 
of gain during the finishing phase 
in steers and heifers. Use of aggres-
sive implant strategies could decrease 
carcass fatness and improve YG but 
reduce QG in heifer and steer calves 
when compared with a traditional im-
plant strategy that uses a lesser-dose 
initial implant followed by a greater-
dose terminal implant.
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